Is EOM Pharmaceuticals Holdings, Inc. (IMUC) a Buy, Sell, or Hold?
EOM Pharmaceuticals Holdings, Inc.
OTC:IMUC
$0.15 USD
-$0.05 (-25.0%)
- Volume
- 13K
- Average Volume
- 7.39K
- Market Capitalization
- $18.98M
- P/E Ratio
- -9.87
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $0.34
- Year Low
- $0.04
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.08
Industry, Sector & symbol
| Stock Exchange | OTC |
| CEO | Irach Taraporewala |
| Industry | Biotechnology |
| Sector | Healthcare |
| Current Symbol | IMUC |
| CUSIP | 452536402 |
| CIK | 0000822411 |
| Web | https://www.eompharma.com |
| Phone | 201-351-0605 |
| Currency | USD |
| Employees | 3 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | -0.73 |
| Payout Ratio | 0.00 |
| Current Ratio | 0.08 |
| Quick Ratio | 0.08 |
| Cash Ratio | 0.03 |
Sales & Book Value
| Annual Sales | $- |
| Price / Sales | 0.00 |
| Cash Flow | -0.01 |
| Price / Cash Flow | -12.70 |
| Price / Book | -7.93 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | N/A |
| Rating Score(0-5) | 0 |
| Research Coverage | 3 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-0.0152 |
| Trailing P/E Ratio | -9.87 |
| PEG Ratio | -0.07 |
| P/E Growth | -0.07 |
| Net Income | $-1.92M |
| Net Margin | 0.00% |
| Pretax Margin | 0.00% |
| Return on Equity | 127.66% |
| Return on Assets | -1933.07% |
Financials Score
| AltmanZ Score | -28.76 |
| Piotroski Score | 2.00 |
| Working Capital | -2.9M |
| Total Assets | 768.8K |
| Ebit | -2.44M |
| Market Cap | 25.3M |
| Total Liabilities | 4.96M |
Poll Results
About EOM Pharmaceuticals Holdings, Inc. (OTC:IMUC) Stock
EOM Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative medications. These treatments hold the potential to revolutionize existing therapeutic approaches. Among its key drug candidates currently undergoing development are EOM613 and EOM147. Established on March 20, 1987, the company maintains its corporate headquarters in Montvale, New Jersey. ...
Frequently Asked Questions
-
What is the current EOM Pharmaceuticals Holdings, Inc. (IMUC) stock price?
-
EOM Pharmaceuticals Holdings, Inc.(OTC:IMUC) stock price is $0.15 in the last trading session. During the trading session, IMUC stock reached the peak price of $0.34 while $0.036 was the lowest point it dropped to. The percentage change in IMUC stock occurred in the recent session was --25.0% while the dollar amount for the price change in IMUC stock was -$-0.05.
-
IMUC's industry and sector of operation?
-
The OTC listed IMUC is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of IMUC?
-
Wayne I. Danson | Chief Financial Officer & Treasurer
Irach Taraporewala | Chief Executive Officer, President & Director
Shalom Z. Hirschman | Co-Founder, Chief Scientific Officer & Medical Director
Eli Goldberger | Founder, Chairman & Chief Operating Officer
| -
How many employees does IMUC have?
-
Number of IMUC employees currently stands at 3. IMUC operates from 136 Summit Avenue, Montvale, NJ 07645, US.
-
Link for IMUC official website?
-
Official Website of IMUC is: https://www.eompharma.com
-
How do I contact IMUC?
-
IMUC could be contacted at phone #201-351-0605 and can also be accessed through its website. IMUC operates from 136 Summit Avenue, Montvale, NJ 07645, US.
-
How many shares of IMUC are traded daily?
-
The average number of IMUC shares traded daily for last 3 months was 7.39K.
-
What is the market cap of IMUC currently?
-
The market value of IMUC currently stands at $18.98M with its latest stock price at $0.15